telocinobufagin and Lung-Neoplasms

telocinobufagin has been researched along with Lung-Neoplasms* in 1 studies

Reviews

1 review(s) available for telocinobufagin and Lung-Neoplasms

ArticleYear
Telocinobufagin Has Antitumor Effects in Non-Small-Cell Lung Cancer by Inhibiting STAT3 Signaling.
    Journal of natural products, 2022, 04-22, Volume: 85, Issue:4

    Non-small-cell lung carcer (NSCLC), the main histological subtype of lung cancer, is responsible for significant morbidity and mortality worldwide. Telocinobufagin, an active compound of the Chinese traditional medicine ChanSu, has antitumor effects, but its mechanism of action remains unknown. Therefore, we investigated the effect of telocinobufagin on NSCLC growth and metastasis and its possible mechanism of action,

    Topics: Animals; Apoptosis; Bufanolides; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Lung Neoplasms; Mice; Signal Transduction; STAT3 Transcription Factor

2022